The British Journal of Clinical Pharmacy
— Volume 1, Issue 10, November 2009
To download the complete issue, please select one of the following formats:
The treatment of multiple myeloma has advanced rapidly over the past few years, with the licensing of several new drugs and combination regimens. Netty Wood and Calum Polwart describe the key changes and why the role of the clinical pharmacist in this therapeutic area is increasing.
A number of initiatives have been introduced at Cambridge University Hospitals NHS Foundation Trust to improve the safety of anticoagulant therapy. In this article, Narinder Bhalla, Helen Howe and Trevor Baglin describe how these initiatives were implemented.
Sapropterin dihydrochloride was licensed at the end of last year for hyperphenylalaninemia (HPA) in patients with phenylketonuria. In this article, the North Central London Formulary and Medicines Management Group review the evidence for its efficacy and safety. By Anthony Grosso and Pritesh Bodalia.
Prescriber’s Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case, you are reviewing a patient with anxiety and depression in whom a change in treatment has caused further problems. By Andrew Husband and Anne-Marie Bailey.
Amanda Parkinson is a pharmacist independent prescriber working in a trauma service in Lancashire Care NHS Foundation Trust. This article describes her unique role within the service. By Shona Kirk.
The past year has produced some significant challenges for oncology pharmacy services, not least from publication of the NCAG and NCEPOD reports. Strategies to address these challenges were among the topics discussed at this year’s British Oncology Pharmacy Association conference. Hannah Pike reports.
Examples of how NHS trusts have been implementing the National Patient Safety Agency alert to promote the safer use of injectable medicines were discussed at this year’s NPSA workshop, sponsored by B Braun. Christine Clark reports.
Factors influencing international drug use, and integrating technology into practice were among the  topics discussed at this year’s European Society of Clinical Pharmacy symposium. By Christine Clark.
Last month the Royal Pharmaceutical Society advertised the post for a new chief executive. Philip Brown describes the qualities that the profession should hope to see in the successful candidate.